Prospective Database of Gastrointestinal Stromal Cell Tumors (GISTs)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Gastrointestinal Stromal Cell Tumors
- Sponsor
- Washington University School of Medicine
- Enrollment
- 187
- Locations
- 1
- Primary Endpoint
- Determine the natural history of small (< 30 mm) SELs discovered evaluated by EUS.
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
Specific Aim 1: To determine patient compliance with a GIST surveillance program Hypothesis: Patient compliance with a GIST surveillance program will be low.
Specific Aim 2: To determine if EUS features of GIST, particularly maximum size, change significantly during a surveillance program.
Hypothesis: EUS features of GIST, particularly maximum size, will not change significantly during a surveillance program.
Specific Aim 3: To determine if EGD measures of GIST size correlate well with EUS measures of GIST size.
Hypothesis: EGD measures of GIST size will correlate well with EUS measured of GIST size.
Investigators
Eligibility Criteria
Inclusion Criteria
- •presenting for EUS with an indication for a SEL in the stomach or esophagus
- •at least 18 years of age
- •able to provide informed consent
Exclusion Criteria
- •no subepithelial lesion in the stomach or esophagus'
- •less than 18 years of age
- •unable to provide informed consent
Outcomes
Primary Outcomes
Determine the natural history of small (< 30 mm) SELs discovered evaluated by EUS.
Time Frame: 3 years
Secondary Outcomes
- Determine the degree of patient compliance with surveillance recommendations.(3 years)
- Describe the diagnostic yield of EUS±FNA in evaluating SELs.(2 weeks)
- Compare SEL size estimation based on EUS, EGD and computer tomography (CT).(1 day)